Can primary immunodeficiencies help to provide insights into infectious risks of therapeutic antibodies?

Nat Rev Immunol. 2010 May;10(5):299-300. doi: 10.1038/nri2764.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antigens, CD20 / immunology
  • Bacterial Infections / etiology*
  • Humans
  • Immunologic Deficiency Syndromes / complications*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antigens, CD20
  • Tumor Necrosis Factor-alpha